Proto Labs Operating Margin vs. Net Income
| PRLB Stock | USD 57.66 0.07 0.12% |
Proto Labs Operating Profit Margin | 0.0467 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.4448 |
|
| |||||
| Operating Profit Margin | 0.0467 | 0.0491 |
|
|
The view summarizes Proto Labs profitability using ratios that relate earnings to revenue, assets, and equity.
Proto Labs' Revenue Composition by Segment
Your Equity Center.
Macro event markers
Revenue Breakdown by Earning Segment for Proto Labs Details
Earnings estimates add context for valuation and forward-looking analysis. The estimates are presented as context for broader analysis and timeframe comparison.
Quarterly Earnings Growth 0.042 | Earnings Share 0.88 | Revenue Per Share | Quarterly Revenue Growth 0.121 | Return On Assets |
Proto Labs market price can diverge from book value, the accounting figure shown on Proto balance sheet. Proto Labs' market capitalization is 1.37 B. A P/B ratio of 2.03 indicates the market values Proto Labs above its accounting book value. Enterprise value stands at 1.25 B. Intrinsic value is an analytical estimate of Proto Labs' underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
It is useful to distinguish Proto Labs' value from its trading price, which are computed with different methods. For Proto Labs, key inputs include a P/E ratio of 27.47, a P/B ratio of 2.03, a profit margin of 3.98%, ROE of 3.16%. By contrast, market price reflects the level where buyers and sellers transact.
Proto Labs Net Income vs. Operating Margin Fundamental Analysis
Financial ratio benchmarking estimates Proto Labs's competitive valuation profile. Proto Labs is rated below average. in operating margin category among its top compatitors. It is rated below average. in net income category among its top compatitors making up about 374,620,811 of Net Income per Operating Margin. Operating Profit Margin is currently estimated at 0.05, marking a shift of 5.24%. Proto Labs reported 0.05 in Operating Profit Margin for the previous period. Earnings multiples remain central to Proto Labs' valuation analysis.Proto Labs' Historical Earnings Breakdown by Geography
Proto Net Income vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Proto Labs |
| = | 0.06 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Proto Labs |
| = | 21.24 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Proto Net Income Comparison
Proto Labs is currently under evaluation. in net income category among its top compatitors.
Proto Labs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Proto Labs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Proto Labs will eventually generate negative long term returns. The profitability progress is the general direction of Proto Labs' change in net profit over the period of time. It can combine multiple indicators of Proto Labs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -25.2 M | -23.9 M | |
| Operating Income | 26.2 M | 49.3 M | |
| Income Before Tax | 31.1 M | 31.3 M | |
| Total Other Income Expense Net | 4.9 M | 5.1 M | |
| Net Income | 21.2 M | 21.2 M | |
| Income Tax Expense | 9.8 M | 10.1 M | |
| Net Loss | -93.1 M | -88.5 M | |
| Net Income From Continuing Ops | 21.2 M | 16.9 M | |
| Non Operating Income Net Other | 121.9 K | 115.8 K | |
| Change To Netincome | 146.9 M | 154.2 M | |
| Net Income Per Share | 0.89 | 1.19 | |
| Income Quality | 3.51 | 3.68 | |
| Net Income Per E B T | 0.68 | 0.58 |
Proto Profitability Driver Comparison
Investors in Proto Labs should monitor its profitability drivers closely, as these factors directly influence long-term investment value. Unexpected events - from macroeconomic disruptions to industry shocks - can significantly alter Proto Labs' earnings outlook and broader investment thesis.
Earnings per Share Projection vs Actual
Use Proto Labs in pair-trading
Pair trading with Proto Labs can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Proto Labs Pair Trading
Proto Labs Pair Trading Analysis
The effectiveness of tax-loss harvesting on Proto Labs depends on finding a suitable replacement asset. Instruments with correlation above 0.9 to Proto Labs typically provide adequate market exposure during the required holding period.
Interpreting the correlation table for Proto Labs: readings above 0.8 indicate strongly correlated pairs with minimal diversification benefit, while readings between -0.2 and +0.2 around Proto Labs suggest near-independence and genuine portfolio diversification value.
Use Correlation analysis and pair trading evaluation for Proto Labs to review hedging context. The view can be extended across sectors or other related groups.Use Investing Themes to Complement your Proto Labs position
Using Proto Labs inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
More Resources for Proto Stock Analysis
A comprehensive view of Proto Labs starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Proto Labs Stock. Key reports that frame Proto Labs Stock are listed below:Your Equity Center. Our How to Invest in Proto Labs guide provides practical guidance on trading Proto Stock.Analysis related to Proto Labs should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Projecting Proto Labs' profitability begins with historical financial statements. The three primary statements are income statement, balance sheet, and cash flow.